Compare Paycom Software Inc (PAYC) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paycom Software Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Paycom Software Inc trades at $232.22 (market cap $10.36B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.73 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 5.7× Paycom Software Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold Paycom Software Inc for 84 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| PAYC | TAK | |
|---|---|---|
Market Cap | $10.36B | $58.74B |
Volume | 666,294 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $240.52 | $19.05 |
52-Week Low | $113.59 | $13.23 |
Typical Hold Time | 84 Days | 1 Days |
Enterprise Value | $11.15B | $86.65B |
Dividend Yield | 0.65% | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paycom Software (PAYC) trades at $229.90, up 2.83% today, with a bullish technical signal and strong earnings momentum after beating estimates for three consecutive quarters. The company reported robust Q2 2026 results with 10% revenue growth and raised full-year guidance, supported by a high gross profit margin of 83.67% and solid cash flow generation. Analyst sentiment is mixed but leans positive, with a consensus price target of $207.75.
The outlook remains favorable due to operational leverage and product innovation, though risks include competitive pressures and market volatility. Upside potential hinges on sustained earnings growth and institutional confidence, while any guidance miss or macroeconomic slowdown could pressure the stock.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
